Literature DB >> 25288038

Effect of intermittent normobaric hyperoxia for treatment of neuropathic pain in Chinese patients with spinal cord injury.

Y Gui1, H Li1, M Zhao1, Q Yang1, X Kuang1.   

Abstract

STUDY
DESIGN: Prospective, randomized and controlled study.
OBJECTIVES: The aim of the study was to investigate the effect of intermittent normobaric hyperoxia (InHO) for treatment of neuropathic pain in patients with spinal cord injury (SCI).
SETTING: The First Affiliated Hospital of Nanhua University, Hengyang, Hunan Province, China.
METHODS: Patients with SCI from Hunan Province were recruited from the First Affiliated Hospital of Nanhua University. History, duration, localization and characteristics of pain were recorded. Visual analog scale (VAS), the Patient Global Impression of Change (PGIC) and Short Form-36 walk-wheel (SF-36ww) was used to investigate the effect of InHO. Patients were randomly assigned to study and control groups. In study group, patients were exposed to pure oxygen via non-rebreathing reservoir mask, which increased the provided oxygen at a rate of 7 l min-1 for 1 or 4 h daily in 2 weeks. While in control group, patients breathed air via non-rebreathing reservoir mask at the same rate.
RESULTS: A total of 62 SCI patients with neuropathic pain were included in the study. The mean age of the patients was 36.85±10.71 years. Out of 62 patients, 21 were tetraplegic and 41 were paraplegic. Overall, 14 patients had complete SCI while 48 patients had incomplete injuries. Three groups were similar with respect to age, gender, duration, smoker or not, level and severity of injury. In the 4 h per day InHO groups, a statistically significant reduction of the VAS values was observed (P<0.05). Significant difference was also found in SF-36ww pain scores and PGIC (P<0.05). However, such an effect was not evident in the control group.
CONCLUSION: This study revealed that in treatment of neuropathic pain of SCI patients, InHO may be effective. PERSPECTIVE: This article presents InHO may effectively complement pharmacological treatment in patients with SCI and neuropathic pain.

Entities:  

Year:  2014        PMID: 25288038     DOI: 10.1038/sc.2014.161

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  34 in total

1.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.

Authors:  Yasuhiko Kawasaki; Zhen-Zhong Xu; Xiaoying Wang; Jong Yeon Park; Zhi-Ye Zhuang; Ping-Heng Tan; Yong-Jing Gao; Kristine Roy; Gabriel Corfas; Eng H Lo; Ru-Rong Ji
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

2.  What is the efficacy of physical therapeutics for treating neuropathic pain in spinal cord injury patients?

Authors:  C Fattal; D Kong-A-Siou; C Gilbert; M Ventura; T Albert
Journal:  Ann Phys Rehabil Med       Date:  2009-02-14

3.  EFNS guidelines on pharmacological treatment of neuropathic pain.

Authors:  N Attal; G Cruccu; M Haanpää; P Hansson; T S Jensen; T Nurmikko; C Sampaio; S Sindrup; P Wiffen
Journal:  Eur J Neurol       Date:  2006-11       Impact factor: 6.089

4.  Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.

Authors:  Fenghua Li; Lili Fang; Shiwei Huang; Zhongjin Yang; Jyotirmoy Nandi; Sebastian Thomas; Chung Chen; Enrico Camporesi
Journal:  Anesth Analg       Date:  2011-05-19       Impact factor: 5.108

5.  Ischemic tolerance induced by normobaric hyperoxia and evaluation of group I and II metabotropic glutamate receptors.

Authors:  Samane Nasrniya; Mohammad Reza Bigdeli
Journal:  Curr Neurovasc Res       Date:  2013-02       Impact factor: 1.990

6.  Transcutaneous electrical nerve stimulation for treatment of spinal cord injury neuropathic pain.

Authors:  Cecilia Norrbrink
Journal:  J Rehabil Res Dev       Date:  2009

Review 7.  Unmet needs in the management of neuropathic pain.

Authors:  Norman Harden; Mitchell Cohen
Journal:  J Pain Symptom Manage       Date:  2003-05       Impact factor: 3.612

Review 8.  Normobaric and hyperbaric oxygen therapy for migraine and cluster headache.

Authors:  Michael H Bennett; Christopher French; Alexander Schnabel; Jason Wasiak; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

9.  Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial.

Authors:  Birsen Ozkurt; Orhan Cinar; Erdem Cevik; Ayhan Yahya Acar; Deniz Arslan; Emrah Yusuf Eyi; Loni Jay; Levent Yamanel; Troy Madsen
Journal:  Am J Emerg Med       Date:  2012-05-03       Impact factor: 2.469

Review 10.  Management of neuropathic pain following spinal cord injury: now and in the future.

Authors:  P J Siddall
Journal:  Spinal Cord       Date:  2008-11-11       Impact factor: 2.772

View more
  2 in total

1.  The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update.

Authors:  Eldon Loh; Magdalena Mirkowski; Alexandria Roa Agudelo; David J Allison; Brooke Benton; Thomas N Bryce; Sara Guilcher; Tara Jeji; Anna Kras-Dupuis; Denise Kreutzwiser; Oda Lanizi; Gary Lee-Tai-Fuy; James W Middleton; Dwight E Moulin; Colleen O'Connell; Steve Orenczuk; Patrick Potter; Christine Short; Robert Teasell; Andrea Townson; Eva Widerström-Noga; Dalton L Wolfe; Nancy Xia; Swati Mehta
Journal:  Spinal Cord       Date:  2022-02-05       Impact factor: 2.473

2.  Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial.

Authors:  Yehudit Bloch; R H Belmaker; Pesach Shvartzman; Pnina Romem; Arkady Bolotin; Yuly Bersudsky; Abed N Azab
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.